Tower Research Capital (TRC)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-5,928
| Closed | -$896K | – | 6983 |
|
|
2022
Q3 | $896K | Sell |
5,928
-999
| -14% | -$151K | 0.01% | 754 |
|
|
2022
Q2 | $1.01M | Buy |
6,927
+5,211
| +304% | +$760K | 0.02% | 681 |
|
|
2022
Q1 | $204K | Sell |
1,716
-787
| -31% | -$93.6K | ﹤0.01% | 1711 |
|
|
2021
Q4 | $344K | Buy |
2,503
+586
| +31% | +$80.5K | 0.01% | 1380 |
|
|
2021
Q3 | $266K | Sell |
1,917
-3,603
| -65% | -$500K | 0.01% | 1535 |
|
|
2021
Q2 | $536K | Buy |
5,520
+1,278
| +30% | +$124K | 0.01% | 1133 |
|
|
2021
Q1 | $290K | Sell |
4,242
-1,797
| -30% | -$123K | ﹤0.01% | 1690 |
|
|
2020
Q4 | $517K | Sell |
6,039
-6,339
| -51% | -$543K | 0.02% | 967 |
|
|
2020
Q3 | $805K | Buy |
12,378
+8,358
| +208% | +$544K | 0.01% | 1191 |
|
|
2020
Q2 | $294K | Buy |
4,020
+3,327
| +480% | +$243K | 0.01% | 1457 |
|
|
2020
Q1 | $24K | Buy |
693
+689
| +17,225% | +$23.9K | ﹤0.01% | 1634 |
|
|
2019
Q4 | $0 | Sell |
4
-1,678
| -100% | – | ﹤0.01% | 4940 |
|
|
2019
Q3 | $70K | Buy |
1,682
+206
| +14% | +$8.57K | ﹤0.01% | 1568 |
|
|
2019
Q2 | $65K | Buy |
+1,476
| New | +$65K | ﹤0.01% | 1441 |
|
|
2019
Q1 | – | Sell |
-3,470
| Closed | -$128K | – | 4783 |
|
|
2018
Q4 | $128K | Sell |
3,470
-1,587
| -31% | -$58.5K | 0.01% | 857 |
|
|
2018
Q3 | $190K | Buy |
5,057
+4,337
| +602% | +$163K | 0.01% | 1010 |
|
|
2018
Q2 | $28K | Sell |
720
-368
| -34% | -$14.3K | ﹤0.01% | 2229 |
|
|
2018
Q1 | $28K | Buy |
+1,088
| New | +$28K | ﹤0.01% | 2009 |
|
|
2017
Q4 | – | Sell |
-1,010
| Closed | -$38K | – | 4678 |
|
|
2017
Q3 | $38K | Sell |
1,010
-9,991
| -91% | -$376K | ﹤0.01% | 2237 |
|
|
2017
Q2 | $275K | Buy |
+11,001
| New | +$275K | 0.03% | 283 |
|